{"transactions":[{"id":2535084,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Earnout Rights (Restricted Stock Units)","published_at":"2021-10-27T01:49:46.000Z","date":"2021-10-22","kind":"grant","acquired":true,"shares":9399,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the earnout provisions in the Business Combination Agreement, the reporting person is entitled to receive shares of New SAB Biotherapeutics common stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the common stock equals or exceeds certain thresholds (the \"Earnout Shares\"). Subject to adjustment as provided in the Business Combination Agreement, the Earnout Shares will be released as follows:"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"25% of the Earnout Shares will be released if within the five-year period after the closing (the \"Earnout Period\"), the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $15.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $20.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $25.00 during at least 20 trading days within a 30-day trading period; and 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $30.00 during at least 20 trading days within a 30-day trading period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the earnout provisions in the Business Combination Agreement, the reporting person is entitled to receive shares of New SAB Biotherapeutics common stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the common stock equals or exceeds certain thresholds (the \"Earnout Shares\"). Subject to adjustment as provided in the Business Combination Agreement, the Earnout Shares will be released as follows:"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"25% of the Earnout Shares will be released if within the five-year period after the closing (the \"Earnout Period\"), the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $15.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $20.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $25.00 during at least 20 trading days within a 30-day trading period; and 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $30.00 during at least 20 trading days within a 30-day trading period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the earnout provisions in the Business Combination Agreement, the reporting person is entitled to receive shares of New SAB Biotherapeutics common stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the common stock equals or exceeds certain thresholds (the \"Earnout Shares\"). Subject to adjustment as provided in the Business Combination Agreement, the Earnout Shares will be released as follows:"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the Earnout Shares will be released if within the five-year period after the closing (the \"Earnout Period\"), the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $15.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $20.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $25.00 during at least 20 trading days within a 30-day trading period; and 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $30.00 during at least 20 trading days within a 30-day trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the earnout provisions in the Business Combination Agreement, the reporting person is entitled to receive shares of New SAB Biotherapeutics common stock if, from the closing of the transaction until the fifth anniversary thereof, the volume-weighted average price of the common stock equals or exceeds certain thresholds (the \"Earnout Shares\"). Subject to adjustment as provided in the Business Combination Agreement, the Earnout Shares will be released as follows:"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the Earnout Shares will be released if within the five-year period after the closing (the \"Earnout Period\"), the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $15.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $20.00 during at least 20 trading days within a 30-day trading period; 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $25.00 during at least 20 trading days within a 30-day trading period; and 25% of the Earnout Shares will be released if within the Earnout Period, the volume weighted share price of the New SAB Biotherapeutics common stock equals or exceeds $30.00 during at least 20 trading days within a 30-day trading period."}],"balance_after":9399,"derivative":{"underlying":"Common Stock","underlying_shares":9399},"source":{"system":"sec-edgar","filing":"0001493152-21-026386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221026386/ownership.xml","form_type":"4"}},{"id":2535083,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-27T01:49:46.000Z","date":"2021-10-22","kind":"grant","acquired":true,"shares":69793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 21, 2021 and as amended August 12, 2021 (the \"Business Combination Agreement\"), by and among Big Cypress Acquisition Corp. (\"BCYP\"), Big Cypress Merger Sub Inc., and SAB Biotherapeutics, Inc. (\"Old SAB Biotherapeutics\"), each security to purchase shares of Old SAB Biotherapeutics common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a conversion rate of $10.10. Upon consummation of the business combination, BCYP changed its name to \"SAB Biotherapeutics, Inc.\" (\"New SAB Biotherapeutics\" or \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option shall vest and become exercisable over a period of 36 months from the Vesting Start Date, January 1, 2021, with 1/12th vesting every three months following the Vesting Start Date, such that the option will be fully vested 36 months from the Vesting Start Date, subject to the reporting person's continuous service with the Issuer on each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 21, 2021 and as amended August 12, 2021 (the \"Business Combination Agreement\"), by and among Big Cypress Acquisition Corp. (\"BCYP\"), Big Cypress Merger Sub Inc., and SAB Biotherapeutics, Inc. (\"Old SAB Biotherapeutics\"), each security to purchase shares of Old SAB Biotherapeutics common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a conversion rate of $10.10. Upon consummation of the business combination, BCYP changed its name to \"SAB Biotherapeutics, Inc.\" (\"New SAB Biotherapeutics\" or \"Issuer\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable over a period of 36 months from the Vesting Start Date, January 1, 2021, with 1/12th vesting every three months following the Vesting Start Date, such that the option will be fully vested 36 months from the Vesting Start Date, subject to the reporting person's continuous service with the Issuer on each such date."}],"balance_after":69793,"derivative":{"exercise_price":1.25,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":69793},"source":{"system":"sec-edgar","filing":"0001493152-21-026386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221026386/ownership.xml","form_type":"4"}},{"id":206630,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2011-03-01T20:08:41.000Z","date":"2011-02-28","kind":"exercise","acquired":false,"shares":4650,"price":32.19,"value":149683.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."}],"balance_after":0,"derivative":{"exercise_date":"2011-02-28","expiration_date":"2011-02-28","underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001225208-11-007802","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520811007802/doc4.xml","form_type":"4"}},{"id":206629,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2011-03-01T20:08:41.000Z","date":"2011-02-28","kind":"tax_withholding","acquired":false,"shares":1691,"price":32.19,"value":54433.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":26423.7647,"source":{"system":"sec-edgar","filing":"0001225208-11-007802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520811007802/doc4.xml","form_type":"4"}},{"id":206628,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2011-03-01T20:08:41.000Z","date":"2011-02-28","kind":"exercise","acquired":true,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28114.7647,"source":{"system":"sec-edgar","filing":"0001225208-11-007802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520811007802/doc4.xml","form_type":"4"}},{"id":206723,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2011-02-24T17:02:31.000Z","date":"2011-02-22","kind":"grant","acquired":true,"shares":3541,"price":32.34,"value":114515.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08.  Performance shares were paid out at 122 percent of target awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":23464.7647,"source":{"system":"sec-edgar","filing":"0001225208-11-007026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520811007026/doc4.xml","form_type":"4"}},{"id":210943,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2010-10-14T21:35:38.000Z","date":"2010-01-08","kind":"grant","acquired":true,"shares":2688,"price":37.72,"value":101391.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/02/2007.  Performance shares were paid out at 120 percent of target awards.  Filing is late due to an administrative oversight by the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":19367.701,"source":{"system":"sec-edgar","filing":"0001209191-10-050440","document":"c06892_4x0.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000120919110050440/c06892_4x0.xml","form_type":"4"}},{"id":210944,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2010-10-14T21:28:31.000Z","date":"2009-11-03","kind":"other","acquired":true,"shares":16565.6788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Due to an administrative oversight by the Company, these shares were not reported on original filing. Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":16565.6788,"source":{"system":"sec-edgar","filing":"0001209191-10-050439","document":"c06893_4ax1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000120919110050439/c06893_4ax1.xml","form_type":"4/A","original_submission_date":"2009-11-06"}},{"id":213885,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2010-05-11T21:33:20.000Z","date":"2010-05-07","kind":"grant","acquired":true,"shares":24010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in three equal annual installments beginning May 7, 2011."}],"balance_after":24010,"derivative":{"exercise_price":33.49,"exercise_date":"2011-05-07","expiration_date":"2020-05-06","underlying":"Common Stock","underlying_shares":24010},"source":{"system":"sec-edgar","filing":"0001225208-10-012655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520810012655/doc4.xml","form_type":"4"}},{"id":213884,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2010-05-11T21:33:20.000Z","date":"2010-05-07","kind":"grant","acquired":true,"shares":2986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."}],"balance_after":2986,"derivative":{"exercise_date":"2013-05-07","expiration_date":"2013-05-07","underlying":"Common Stock","underlying_shares":2986},"source":{"system":"sec-edgar","filing":"0001225208-10-012655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520810012655/doc4.xml","form_type":"4"}},{"id":219708,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":24800,"derivative":{"exercise_price":23.45,"exercise_date":"2010-04-24","expiration_date":"2019-04-23","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219707,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":24800,"derivative":{"exercise_price":44.3,"exercise_date":"2009-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219706,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":35000,"derivative":{"exercise_price":44.19,"exercise_date":"2008-03-03","expiration_date":"2017-03-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219705,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":13334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":13334,"derivative":{"exercise_price":35.09,"exercise_date":"2007-03-03","expiration_date":"2016-03-02","underlying":"Common Stock","underlying_shares":13334},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219704,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":3334,"derivative":{"exercise_price":34.47,"exercise_date":"2007-02-01","expiration_date":"2016-01-31","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219703,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":21099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":21099,"derivative":{"exercise_price":75.76,"exercise_date":"2006-03-02","expiration_date":"2011-03-01","underlying":"Common Stock","underlying_shares":21099},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219702,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":5834,"derivative":{"exercise_price":31.84,"exercise_date":"2006-02-25","expiration_date":"2015-02-24","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219701,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":3334,"derivative":{"exercise_price":28.9,"exercise_date":"2005-11-01","expiration_date":"2014-10-31","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219700,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":7500,"derivative":{"exercise_price":47.39,"exercise_date":"2005-05-03","expiration_date":"2014-05-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219699,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":17500,"derivative":{"exercise_price":48.24,"exercise_date":"2005-02-27","expiration_date":"2014-02-26","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219698,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":25319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":25319,"derivative":{"exercise_price":62.09,"exercise_date":"2005-02-22","expiration_date":"2010-02-21","underlying":"Common Stock","underlying_shares":25319},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219697,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":26374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":26374,"derivative":{"exercise_price":49.96,"exercise_date":"2004-02-28","expiration_date":"2013-02-27","underlying":"Common Stock","underlying_shares":26374},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219696,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Option (right to buy)","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":18989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger."}],"balance_after":18989,"derivative":{"exercise_price":58.91,"exercise_date":"2003-03-01","expiration_date":"2012-02-29","underlying":"Common Stock","underlying_shares":18989},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219695,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions."}],"balance_after":4650,"derivative":{"exercise_price":0,"exercise_date":"2012-04-24","expiration_date":"2012-04-24","underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219694,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":16722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions."}],"balance_after":16722,"derivative":{"exercise_price":0,"exercise_date":"2011-09-01","expiration_date":"2011-09-01","underlying":"Common Stock","underlying_shares":16722},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219693,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions."}],"balance_after":4650,"derivative":{"exercise_price":0,"exercise_date":"2011-02-28","expiration_date":"2011-02-28","underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219692,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"disposition_to_issuer","acquired":false,"shares":64,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (\"Merger Agreement\") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, (\"New Merck\") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the \"Transactions\"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash.  Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement."}],"balance_after":86,"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}},{"id":219691,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":13067,"kind":"person","name":"Turner Mervyn","position":1,"cik":"0001475383","reported_name":"Turner Mervyn","relationship":{"officer":true,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock - 401(k) Plan","published_at":"2009-11-09T16:01:13.000Z","date":"2009-11-03","kind":"other","acquired":true,"shares":1221.8905,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received as part of the Transactions in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (\"MSD\") common stock held under the MSD 401(k) plan."}],"balance_after":1221.8905,"source":{"system":"sec-edgar","filing":"0001225208-09-021927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021927/doc4.xml","form_type":"4"}}]}